Skip to main content
BrainCited

N-Acetyl Cysteine for Post-Concussion Cognitive Symptoms

B

NAC demonstrated neuroprotective effects in traumatic brain injury models. MRI studies showed improvements in resting-state brain connectivity in mild TBI patients receiving NAC treatment.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dn\u002Dacetyl\u002Dcysteine\u0026condition\u003Dpost\u002Dconcussion'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

The Bottom Line

NAC demonstrated neuroprotective effects in traumatic brain injury models. MRI studies showed improvements in resting-state brain connectivity in mild TBI patients receiving NAC treatment.

Key Study Findings

Randomized Controlled Trial n=50 Open-label
Changes in Resting-State Functional Connectivity and Cognitive-Affective Symptoms in Patients With Post-Concussion Syndrome Treated With …
Dose: None vs: waitlist control (standard of care) Outcome: resting-state functional connectivity and cognitive-affective symptoms Effect: None p<0.05

Population: patients with chronic post-concussion syndrome for at least 3 months

Review
Mitigating Traumatic Brain Injury: A Narrative Review of Supplementation and Dietary Protocols.
Dose: None vs: None Outcome: TBI prevention and neuroprotection Effect: None None

Population: Individuals with or at risk for TBI

Controlled Clinical Trial n=65 4 weeks Open-label
N -acetylcysteine is associated with reduction of postconcussive symptoms in elderly patients: A pilot study.
Dose: None vs: Standard care alone Outcome: RPQ postconcussion symptom severity Effect: RPQ day 7: 2 vs 10; day 30: 0 vs 4 p=0.004 (day 7); p=0.021 (day

Population: Elderly patients (>=60y) with mild TBI

Review
Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox.
Dose: None vs: None Outcome: None Effect: None None

Population: restless legs syndrome

Review
Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?
Dose: None vs: None Outcome: None Effect: None None

Population: None

Review
Dietary Supplements for Health, Adaptation, and Recovery in Athletes.
Dose: None vs: None Outcome: Health, adaptation, and recovery in athletes Effect: None None

Population: Athletes

Key Statistics

6

Studies

400

Participants

Positive

B

Grade

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

general:
600-1,800 mg/day
neuroprotection:
1,200-2,400 mg/day

Upper limit: Not established as supplement; 6,000+ mg/day used clinically (IV)

Dosages Studied in Research

Dosage Duration Effect N
None -- Positive 50
None -- Positive --
None 4 weeks Positive 65
None -- Mixed --
None -- Positive --
None -- Mixed --
NAC 100 mg/kg body weight orally daily for 14 days 2 weeks Positive 24
None -- Mixed --

Best taken: On empty stomach; split into 2-3 doses; supplement zinc if using long-term

Safety & Side Effects

Reported Side Effects

  • Nausea and vomiting
  • Diarrhea
  • Unpleasant sulfur taste/smell
  • Rare: bronchospasm (inhaled form)
  • Long-term use may deplete zinc stores

Known Interactions

  • Nitroglycerin (may enhance hypotensive effects)
  • Activated charcoal (reduces NAC absorption)
  • Anticoagulants (theoretical interaction)

Tolerable upper intake: Not established as supplement; 6,000+ mg/day used clinically (IV)

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does N-Acetyl Cysteine help with Post-Concussion Cognitive Symptoms?
Based on 6 studies with 400 participants, there is moderate evidence from clinical studies that N-Acetyl Cysteine may support Post-Concussion Cognitive Symptoms management. Our evidence grade is B (Good Evidence).
How much N-Acetyl Cysteine should I take for Post-Concussion Cognitive Symptoms?
Studies have used various dosages. A commonly studied range is 600-1,800 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of N-Acetyl Cysteine?
Reported side effects may include Nausea and vomiting, Diarrhea, Unpleasant sulfur taste/smell, Rare: bronchospasm (inhaled form). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for N-Acetyl Cysteine and Post-Concussion Cognitive Symptoms?
We rate the evidence as Grade B (Good Evidence). This rating is based on 6 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.